COVID-19 Tech Strategy
CLINICAL TRIALS HAVE CHANGED.
HAS YOUR TECH STRATEGY?
A five-part series to optimize your tech response to COVID-19 challenges
The pandemic continues to disrupt clinical trials. Its impact on patients and sites is propelling long-lasting changes, pressuring sponsors to rapidly respond to evolving requirements and updated guidance issued by global agencies.
New challenges require new tech strategies.
Engage your CRO in technology discussions to ensure your tech strategy delivers the fastest and safest response to new priorities.
Understand the technology options that will ensure your trial’s success during COVID-19 and beyond.
Get Personalized assessments and resources
MODULE 1 | WHY NOW?
Do you know how COVID-19 has disrupted sites?
MODULE 2 | PATH TO VIRTUALIZATION
Discover the best options to your virtualization approach
MODULE 3 | PIVOT FASTER
Evaluate the alternatives to drive faster trials
MODULE 4 | LEAD WITH DATA
Leverage data to protect patients, sites, and study integrity
MODULE 5 | THE CTO REPORT
The latest developments and trends for new technology deployment